Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04743609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

RSV Burden in Outpatient and Hospital Settings

Study acronym: Oursyn
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not specified to Not applicablev7 Show 8 more changesShow less
    • Enrollment target: 3500 to 1900
    • Primary and study completion dates: Jan 11, 2024 to Dec 8, 2026
    • Primary endpoint revised
    • Eligibility criteria shortened, about 59 words
    • Secondary endpoints revised (7)
    • Publications: 3 to 4
    • Study arms: 3 to 2
    • Study title expanded, about 2 words
  2. Primary completion date: Jun 11, 2023 to Jan 11, 2024
    • Enrollment target: 2900 to 3500
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Primary completion date: Jun 11, 2022 to Jun 11, 2023
    • Study completion date: Jan 11, 2023 to Jan 11, 2024
    v4
  5. Enrollment target: 1600 to 2900
    • Primary completion date: Jul 11, 2021 to Jun 11, 2022
    • Publications: details revised at 1 of 3 entries
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2021 to Feb 8, 2021
    • Site details revised
    • Collaborators expanded, about 1 word
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Trial Details
NCT Number NCT04743609
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Sanofi
Conditions
(from sponsor)		 RSV Infection, Children, Only, Outpatient, Otitis
Related terms Otitis, Respiratory Syncytial Virus Infections
Enrollment 1,900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov